3894. Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial.
作者: Christopher W Ryan.;Catherine M Tangen.;Elisabeth I Heath.;Mark N Stein.;Maxwell V Meng.;Ajjai S Alva.;Sumanta K Pal.;Igor Puzanov.;Joseph I Clark.;Toni K Choueiri.;Neeraj Agarwal.;Robert G Uzzo.;Naomi B Haas.;Timothy W Synold.;Melissa Plets.;Ulka N Vaishampayan.;Brian M Shuch.;Ian M Thompson.;Primo N Lara.
来源: Lancet. 2023年402卷10407期1043-1051页
Patients undergoing resection of renal cell carcinoma are at risk of disease relapse. We evaluated the effectiveness of the mammalian target of rapamycin inhibitor everolimus administered after surgery.
3898. Intracerebral haemorrhage caused by Iatrogenic cerebral amyloid angiopathy in a patient with a history of neurosurgery 35 years earlier.
作者: Simon Fandler-Höfler.;Markus Kneihsl.;Markus Beitzke.;Christian Enzinger.;Thomas Gattringer.
来源: Lancet. 2023年402卷10399期411页 |